All In MedTech

Device Trial Radar · NCT04908124

A Clinical Investigation Into the Effectiveness and Safety of Five Water Based Personal Lubricants.

An Open Label, Parallel-design, Clinical Investigation to Determine the Effectiveness and Safety of Five Water Based Personal Lubricants for the Relief of Intimate Discomfort Associated With Vaginal Dryness.

Last checked: Nov 19, 2026Latest source record: Jul 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 183 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

183

Actual

Start

Mar 1, 2021

Primary completion

Jun 29, 2021

Study completion Jun 29, 2021

Sponsor

Lead sponsor
Reckitt Benckiser Healthcare (UK) LimitedNot on our public-company list
Sponsor type
Industry
Collaborators
proDERM GmbH
First posted
Jun 1, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This clinical investigation will look at the safety of five water based personal lubricants, and teir effectiveness the relief of intimate discomfort associated with vaginal dryness.

Conditions

  • Dyspareunia
  • Vaginal Dryness

Interventions

  • Lubricant ADevice

    Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.

  • Lubricant BDevice

    Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.

  • Lubricant CDevice

    Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.

  • Lubricant DDevice

    Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.

  • Lubricant EDevice

    Water-based lubricant, which is suitable for oral, anal and vaginal sexual intercourse. Approximately 3g of lubricant will be considered a single application.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Female Sexual Function Index (FSFI) score compared to baselineTime frame: 4 weeks after baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • proDERM GmbH

    Hamburg, Pinneberg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.